Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Hormonal therapies are safe and effective for treating adult women's acne.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Bimatoprost is safe and effective for improving eyebrow hair.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Gastric exclusion surgery caused major weight loss and health improvements but led to some anemia and vitamin deficiencies.

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Hydroxychloroquine may help treat alopecia areata in children.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Tamoxifen caused hair loss in a 52-year-old woman.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Young women with PCOS without additional risk factors may have normal heart function.